Marksans Pharma Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Sep '25
    Jun '25
    Mar '25
    Dec '24
    Sep '24
    Total Qtr Revenue cr
    741.98
    625.63
    724.98
    709.70
    652.98
    Other Income Qtr Cr21.575.6416.5227.8511.06
    Operating Revenues Qtr720.41619.99708.46681.85641.92
    Loading chart...
    Operating Expenses Qtr
    575.92
    519.87
    582.70
    543.08
    506.24
    Operating Profit Qtr
    144.49
    100.12
    125.75
    138.76
    135.68
    EBITDA Qtr Cr
    166.06
    105.76
    142.27
    166.61
    146.74
    Depreciation Qtr
    26.92
    23.10
    22.74
    20.69
    19.51
    Net Profit Qtr
    98.25
    58.32
    90.55
    104.56
    96.72
    Basic EPS Qtr
    2.17
    1.29
    2.00
    2.31
    2.13
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -